Head and Neck Cancers

Oncology·MeSH: Head and Neck Neoplasms

6 drugs in development·4 companies·1 clinical trial

Drug Pipeline by Phase

Approved(2)

Drug	Company
Erbitux	ELI LILLY & Co (LLY)
Erbitux®	ELI LILLY & Co (LLY)

Phase 2(2)

Drug	Company
eseba-vec	HOOKIPA Pharma Inc. (HOOK)
hb-200	HOOKIPA Pharma Inc. (HOOK)

Preclinical(2)

Drug	Company
apvo455	Aptevo Therapeutics Inc. (APVO)
VPS4A inhibitors (novel series)	Calithera Biosciences, Inc. (CALA)

BioSniper tracks 6 drugs in development for Head and Neck Cancers across 4 companies.

There are 1 clinical trial targeting Head and Neck Cancers tracked by BioSniper.

Full trial data, competitive analysis, and AI-powered pipeline tracking.